麻豆传媒

Boston, MA USA

Our 麻豆传媒 on 麻豆传媒
View All >

Dana-Farber Researchers to Present Key Transplant and Cellular Therapy Studies at 2025 Tandem Meetings

Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier conference in hematopoietic cell transplantation (HCT) and cellular therapy.
12-Feb-2025 8:10 PM EST Add to Favorites

麻豆传媒: 67ab739b28b14_YawkeyEvening.jpg

Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium, on February 13-15, 2025. The Dana-Farber led research exemplifies innovative and multidisciplinary expertise...
11-Feb-2025 7:55 PM EST Add to Favorites

麻豆传媒: 67a241740cd7c_DanaFarberBuilding.jpg

Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after...
5-Feb-2025 11:30 AM EST Add to Favorites

麻豆传媒: 679a768586b33_BradleyBernsteinSOG1200.jpg

AI Model Learns Generalized 鈥淟anguage鈥� of Regulatory Genomics, Predicts Cellular Stories

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia University have created an artificial intelligence model that can predict which genes are expressed in any type of human cell.
29-Jan-2025 7:20 PM EST Add to Favorites

Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may...
25-Jan-2025 10:05 AM EST Add to Favorites

麻豆传媒: 679144486291a_MohammadRashidianPhD.jpg

PET Probe Images Inflammation with High Sensitivity and Selectivity

Researchers at Dana-Farber Cancer Institute have developed a breakthrough method to detect inflammation in the body using positron emission tomography (PET) imaging. This innovative probe targets CD45, a marker abundantly expressed on all immune...
22-Jan-2025 9:10 PM EST Add to Favorites

Phase 2 LITESPARK-003 Results Suggest Continued Study of Novel First-Line Combo for Advanced Kidney Cancer

Current first-line treatment for advanced clear-cell renal cell carcinoma includes anti-PD1 or anti-PD-L1 immunotherapy in combination with a CTLA-4 inhibitor or a VEGF tyrosine kinase inhibitor such as cabozantanib. These options have improved...
17-Jan-2025 9:00 AM EST Add to Favorites

麻豆传媒: 6785185f54be5_TransatlanticConfImage.jpg

Dana-Farber and Gustave Roussy announce 2025 Transatlantic Exchange scientific program to focus on Radioligand Therapy

Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the Fourth Transatlantic Exchange in Oncology Conference topic will be 鈥淩adiopharmaceutical Therapy Meets Oncology.鈥� The...
13-Jan-2025 9:00 AM EST Add to Favorites


See All News

Our Experts on News

Movie release prompts national conversation about colorectal cancer in the Black community

Marvel Studios鈥� movie, 鈥淏lack Panther: Wakanda Forever,鈥� is the highly anticipated sequel to 鈥淏lack Panther,鈥� hitting theaters on November 11th. It will premiere without 鈥淏lack Panther鈥� star Chadwick Boseman, who passed away in 2020...
8-Nov-2022 3:05 PM EST

麻豆传媒: Yawkey Building 2.jpg

Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
25-Jan-2021 12:05 PM EST

麻豆传媒: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

麻豆传媒: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

麻豆传媒: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

麻豆传媒: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

麻豆传媒: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

麻豆传媒: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

See All Experts

Our YouTube Videos
View All >

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Experts

Twitter

Facebook

close
0.40933